The interaction study found opposite exposure directions for the parent drug and two measured metabolites.
Rat liver microsomes and a rat pharmacokinetic experiment were used to study acacetin with diazepam. Acacetin inhibited formation of temazepam and nordiazepam in the microsomal system. Pretreatment increased diazepam peak and total exposure and reduced its apparent clearance, while metabolite total exposures decreased. Molecular docking supported a possible shared-binding-pocket explanation.
These were animal, laboratory and computational observations, without a human interaction trial. Species differences, pretreatment conditions and the acacetin preparation affect extrapolation. Docking does not independently demonstrate a clinical enzyme interaction. Reduced metabolite exposure cannot be read as reduced overall sedative burden when parent exposure rose.
A toxicology opinion should identify which analyte increased, which decreased and when samples were obtained. Parent-to-metabolite patterns may reflect formation and elimination processes as well as time since administration. This study supplies a plausible interaction hypothesis to investigate if a relevant product was actually taken. It cannot establish human accumulation, impairment or a dose-adjustment factor merely from a history of herbal use, and it does not validate a metabolic ratio as a clock.
Source: PMC12749239, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.
Related: Moschus–Diazepam Rat Microdialysis Findings Do Not Directly Measure Sedative Depth.